JP2014501496A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501496A5 JP2014501496A5 JP2013534446A JP2013534446A JP2014501496A5 JP 2014501496 A5 JP2014501496 A5 JP 2014501496A5 JP 2013534446 A JP2013534446 A JP 2013534446A JP 2013534446 A JP2013534446 A JP 2013534446A JP 2014501496 A5 JP2014501496 A5 JP 2014501496A5
- Authority
- JP
- Japan
- Prior art keywords
- aurka
- gist
- years
- expression
- risk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10013806.4 | 2010-10-20 | ||
| EP10013806 | 2010-10-20 | ||
| PCT/IB2011/054688 WO2012052954A1 (en) | 2010-10-20 | 2011-10-20 | Signatures of clinical outcome in gastro intestinal stromal tumors and method of treatment of gastroinstestinal stromal tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014501496A JP2014501496A (ja) | 2014-01-23 |
| JP2014501496A5 true JP2014501496A5 (https=) | 2016-02-04 |
Family
ID=44999817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013534446A Pending JP2014501496A (ja) | 2010-10-20 | 2011-10-20 | 消化管間質腫瘍における臨床転帰のシグネチャーおよび消化管間質腫瘍の治療の方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20130288250A1 (https=) |
| EP (1) | EP2630259B8 (https=) |
| JP (1) | JP2014501496A (https=) |
| CA (1) | CA2811744A1 (https=) |
| DK (1) | DK2630259T3 (https=) |
| ES (1) | ES2541054T3 (https=) |
| WO (1) | WO2012052954A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3064594A1 (en) | 2015-03-06 | 2016-09-07 | Université de Bordeaux | Signature of clinical outcome in uterine smooth muscle tumor analysis, and method of diagnosis thereof |
| KR101860652B1 (ko) | 2015-12-23 | 2018-05-24 | 연세대학교 산학협력단 | 위장관 간질 종양 진단용 마커 및 위장관 간질 종양의 진단 방법 |
| JP6965621B2 (ja) * | 2017-08-02 | 2021-11-10 | 富士通株式会社 | 検出プログラム、検出方法及び検出装置 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2491067A1 (en) * | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
| WO2006129064A1 (en) * | 2005-05-28 | 2006-12-07 | Astrazeneca Ab | Quinazolines and their use as aurora kinase inhibitors |
| CN101233129A (zh) * | 2005-05-31 | 2008-07-30 | 普法尔家族联合企业（1996.7.9） | 取代的联芳杂环衍生物作为蛋白激酶抑制剂治疗癌症及其他疾病 |
| CA2644586A1 (en) * | 2006-03-03 | 2008-04-17 | Veridex Llc | Molecular assay to predict recurrence of duke's b colon cancer |
| WO2008025526A1 (en) * | 2006-08-31 | 2008-03-06 | F. Hoffmann-La Roche Ag | Indole derivatives, their manufacture and use as pharmaceutical agents |
| EP2102360A2 (en) * | 2006-12-13 | 2009-09-23 | Oncotherapy Science, Inc. | Ttk as tumor marker and therapeutic target for lung cancer |
| CA2690557A1 (en) * | 2007-06-14 | 2008-12-24 | Schering Corporation | Imidazopyrazines as protein kinase inhibitors |
| US9101631B2 (en) * | 2008-12-12 | 2015-08-11 | Georgetown University | Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancer |
-
2011
- 2011-10-20 US US13/880,155 patent/US20130288250A1/en not_active Abandoned
- 2011-10-20 CA CA2811744A patent/CA2811744A1/en not_active Abandoned
- 2011-10-20 DK DK11785107.1T patent/DK2630259T3/en active
- 2011-10-20 EP EP11785107.1A patent/EP2630259B8/en not_active Not-in-force
- 2011-10-20 JP JP2013534446A patent/JP2014501496A/ja active Pending
- 2011-10-20 WO PCT/IB2011/054688 patent/WO2012052954A1/en not_active Ceased
- 2011-10-20 ES ES11785107.1T patent/ES2541054T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Aden et al. | Metabolic functions of gut microbes associate with efficacy of tumor necrosis factor antagonists in patients with inflammatory bowel diseases | |
| Guo et al. | Multiwalled carbon nanotube-induced gene signatures in the mouse lung: potential predictive value for human lung cancer risk and prognosis | |
| Chen et al. | Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis | |
| Zhu et al. | A long non-coding RNA signature to improve prognosis prediction of gastric cancer | |
| Vergho et al. | Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma | |
| US10016159B2 (en) | Determination of TGF-β pathway activity using unique combination of target genes | |
| Farrell et al. | The identification of circulating MiRNA in bovine serum and their potential as novel biomarkers of early Mycobacterium avium subsp paratuberculosis infection | |
| JP2018505658A5 (https=) | ||
| JP2016507233A5 (https=) | ||
| CN105492630A (zh) | 使用靶基因表达的数学建模评价pi3k细胞信号传导途径活性 | |
| RU2015125575A (ru) | Композиции и способы для лечения злокачественной опухоли | |
| EP3729439A1 (en) | Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression | |
| CN104024851A (zh) | 针对癌症的紫杉醇反应标志物 | |
| JP2020535823A (ja) | 標的遺伝子発現の数学的モデル化を使用する、ｊａｋ−ｓｔａｔ３細胞シグナル伝達経路活性の評価 | |
| CN104046624B (zh) | 用于肺癌预后的基因及其应用 | |
| JP2017529859A5 (https=) | ||
| CN106897579A (zh) | 基于染色体变异指数的新型早期肿瘤标记物及应用 | |
| Wang et al. | A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC) | |
| JP2022524484A (ja) | がん患者の生存率を予測する方法 | |
| Xiong et al. | Correlation between chromatin epigenetic-related lncRNA signature (CELncSig) and prognosis, immune microenvironment, and immunotherapy in non-small cell lung cancer | |
| Kim et al. | A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population | |
| Wang et al. | Integrating PANoptosis insights to enhance breast cancer prognosis and therapeutic decision-making | |
| JP2014501496A5 (https=) | ||
| Meriranta et al. | Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma | |
| CN103911440B (zh) | 一种与铂类化疗药物肝脏毒性相关的snp标志物及其应用 |